FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Apotex Bromfenac Ophthalmic Solution 0 Recall

Bromfenac Ophthalmic Solution 0

Apotex Inc. · Toronto, N/A

Risk level
Class II
Reported by FDA
Oct 21, 2015
Recall ID
D-0009-2016
Check your lot numberHow we source this data

Summary

Apotex recalled Bromfenac Ophthalmic Solution 0 starting Aug 25, 2015. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0009-2016 on Oct 21, 2015. Reason: Lack of Assurance of Sterility: Failed preservative effectiveness testing. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility: Failed preservative effectiveness testing

Product description

Bromfenac Ophthalmic Solution 0.09%, packaged in a) 1.7 mL bottle (NDC 60505-0595-05), b) 2.5 mL bottle (NDC 60505-0596-04), Rx Only, Mfg for: Apotex Corp., Weston, FL 33326.

Lot numbers, UPCs & expiration codes

Lot #: a) MF0537, Exp 07/2016; b) MF8090, MF0532, Exp 07/2016

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0009-2016
Classification
Class II
Status
Terminated
Recall initiated
Aug 25, 2015
FDA report date
Oct 21, 2015
Quantity
5,520 bottles (Lot MF0537), 2,828 bottles (Lot MF8090), and 20,454 bottles (Lot MF0532)
Recall type
Voluntary: Firm initiated
Recalling firm
Apotex Inc.

Original FDA data

Every field from FDA enforcement report D-0009-2016, exactly as published.

Show all FDA fields
City
Toronto
Status
Terminated
Country
Canada
Event ID
72341
Address
150 Signet Drive
Code information
Lot #: a) MF0537, Exp 07/2016; b) MF8090, MF0532, Exp 07/2016
Report date
Oct 21, 2015
Product type
Drugs
Recall number
D-0009-2016
Classification
Class II
Recalling firm
Apotex Inc.
Product quantity
5,520 bottles (Lot MF0537), 2,828 bottles (Lot MF8090), and 20,454 bottles (Lot MF0532)
Termination date
Jun 15, 2022
Reason for recall
Lack of Assurance of Sterility: Failed preservative effectiveness testing
Voluntary / mandated
Voluntary: Firm initiated
Product description
Bromfenac Ophthalmic Solution 0.09%, packaged in a) 1.7 mL bottle (NDC 60505-0595-05), b) 2.5 mL bottle (NDC 60505-0596-04), Rx Only, Mfg for: Apotex Corp., Weston, FL 33326.
Distribution pattern
Nationwide
Recall initiation date
Aug 25, 2015
Initial firm notification
Letter
Center classification date
Oct 9, 2015

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0009-2016, published Oct 21, 2015. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls